UK Drug Pricing Talks Collapse, Drugmakers Reject Offer Citing 'Uncompetitive' System

Drug pricing talks between the U.K. government and pharmaceutical companies collapsed Friday, with industry leaders warning the standoff could deter investment. Health Secretary Wes Streeting described the government's offer as "unprecedented," but drugmakers argued that it still imposed excessive costs and requested to negotiate directly with Prime Minister Keir Starmer.

The Labour government has pledged to encourage investment to boost productivity. However, those goals clash with tight public finances and promises to overhaul the NHS.

The dispute has also unfolded against the backdrop of U.S. pressure on drugmakers. President Donald Trump is reportedly urging companies to align global prices more closely with higher U.S. levels.

Also Read: Pharmaceutical Firms Say UK Investment Is ‘Unlikely’ Unless Payment Levy Is Addressed

At the center of the